Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Del Prato

Showing results (1-10 of 361) with videos related to

Pageof 37
Sort By:
International Journal of Clinical Practice. Supplement|September 5, 2007
Type 2 diabetes mellitus: focus on new treatments and special populationsStefano Del Prato
European Endocrinology|April 11, 2018
Ten Years of VildagliptinStefano Del Prato
Diabetes, Obesity & Metabolism|September 2, 2005
Unlocking the opportunity of tight glycaemic control. Far from goalStefano Del Prato
The Lancet. Diabetes & Endocrinology|September 6, 2014
Fixed-ratio combination of basal insulin and GLP-1 receptor agonist: is two better than one?Stefano Del Prato
Nature Reviews. Endocrinology|April 9, 2009
Genes, diabetes and cardiovascular risk predictionStefano Del Prato
The Lancet. Diabetes & Endocrinology|July 27, 2019
Heterogeneity of diabetes: heralding the era of precision medicineStefano Del Prato
The Lancet. Diabetes & Endocrinology|September 26, 2024
Dysglycaemia in cardiovascular disease: what's the best glycaemic risk predictor?Stefano Del Prato
Vascular Pharmacology|November 30, 2023
Diabetes and vascular disease: New therapeutic avenuesStefano Del Prato
Expert Opinion on Pharmacotherapy|September 3, 2011
Linagliptin for the treatment of type 2 diabetesStefano Del Prato
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 22, 2006
Tackling hyperglycemia: a more comprehensive approachStefano Del Prato
Pageof 37

Showing results (1-10 of 361) with videos related to

Sort By:
Pageof 37
International Journal of Clinical Practice. Supplement|September 5, 2007
Type 2 diabetes mellitus: focus on new treatments and special populationsStefano Del Prato
European Endocrinology|April 11, 2018
Ten Years of VildagliptinStefano Del Prato
Diabetes, Obesity & Metabolism|September 2, 2005
Unlocking the opportunity of tight glycaemic control. Far from goalStefano Del Prato
The Lancet. Diabetes & Endocrinology|September 6, 2014
Fixed-ratio combination of basal insulin and GLP-1 receptor agonist: is two better than one?Stefano Del Prato
Nature Reviews. Endocrinology|April 9, 2009
Genes, diabetes and cardiovascular risk predictionStefano Del Prato
The Lancet. Diabetes & Endocrinology|July 27, 2019
Heterogeneity of diabetes: heralding the era of precision medicineStefano Del Prato
The Lancet. Diabetes & Endocrinology|September 26, 2024
Dysglycaemia in cardiovascular disease: what's the best glycaemic risk predictor?Stefano Del Prato
Vascular Pharmacology|November 30, 2023
Diabetes and vascular disease: New therapeutic avenuesStefano Del Prato
Expert Opinion on Pharmacotherapy|September 3, 2011
Linagliptin for the treatment of type 2 diabetesStefano Del Prato
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 22, 2006
Tackling hyperglycemia: a more comprehensive approachStefano Del Prato
Pageof 37